Sort
34,240 grants matching “atherosclerosis”
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis
$734,885Hong Chen · Boston Children'S Hospital · R01 · FY2025 · HL
The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study
$734,868Danxia Yu · Vanderbilt University Medical Center · R01 · FY2022 · DK
Thromboregulation in Occlusive Vascular Diseases
$734,799Aaron J. Marcus · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · HL
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
$734,749Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · HL
Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical Trial
$734,722Pankaj Arora · University Of Alabama At Birmingham · R01 · FY2025 · HL
Epigenome-Wide Association Study of DNA Methylation and Atherosclerosis
$734,646Yongmei Liu · Wake Forest University Health Sciences · R01 · FY2009 · HL
Effect of Chronic Inflammation on Atherosclerosis Outcomes in RA
$734,491Inmaculada Del Rincon · University Of Texas Hlth Science Center · R01 · FY2009 · HL
Small molecule therapies targeting chromatin architecture in heart failure
$734,487Thomas Martin Vondriska · University Of California Los Angeles · R01 · FY2020 · HL
Translational Studies of Age-Associated Arterial Dysfunction, Western Diet and Aerobic Exercise: Role of the Gut Microbiome
$734,456Douglas R Seals · University Of Colorado · R01 · FY2018 · HL
CHARGE consortium: gene discovery for CVD and aging phenotypes
$734,456Bruce M Psaty · University Of Washington · R01 · FY2018 · HL
Cardiac function as a mechanism for maladaptive brain aging
$734,355Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2019 · AG
EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASE
$734,347Stephen Mark Schwartz · University Of Washington · T32 · FY2010 · HL
Dietary Mitigation of Psychosocial Stress Effects on CVD Risk
$734,317Carol A. Shively · Wake Forest University Health Sciences · R01 · FY2016 · HL
Activation trajectories of integrin ñ5ò1
$734,302Timothy A Springer · Boston Children'S Hospital · R01 · FY2021 · HL
Activation trajectories of integrin ñ5ò1
$734,302Timothy A Springer · Boston Children'S Hospital · R01 · FY2022 · HL
Activation trajectories of integrin ñ5ò1
$734,302Timothy A Springer · Boston Children'S Hospital · R01 · FY2023 · HL
Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH
$734,199Ana Morales Reyes · Geisinger Clinic · R01 · FY2025 · HL
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis
$734,089M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2020 · HL
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis
$734,089M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2022 · HL
Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis
$734,089M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2021 · HL
Sex-Specific Risk of Metabolic and Cardiovascular Disease
$733,978John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2025 · HL
Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension
$733,855Casey Marie Rebholz · Johns Hopkins University · R01 · FY2022 · HL
Genetic Determinants of Premature Vascular Dysfunction in Families
$733,832Dhananjay Madhukar Vaidya · Johns Hopkins University · R01 · FY2009 · HL
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics
$733,763Ira A Tabas · Columbia University Health Sciences · R01 · FY2019 · HL
Individual response to vitamin D treatment
$733,529Bryan R Kestenbaum · University Of Washington · R01 · FY2018 · HL